3 recruiting, 1 withdrawn. 4 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Recruiting 3, Withdrawn 1 |
Follow GT307 injection: new trials by email Literature Review of GT307 injection trials Research Report on GT307 injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors GT307 injection - Advanced Solid Tumors | Not applicable | Withdrawn | Grit Biotechnology | 2026-04-30 | 2026-06-09 | |
| Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours GT307 injection - Adult | Not applicable | Recruiting | Grit Biotechnology | 18 | 2024-07-04 | 2026-04-14 |
| Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Advanced Colorectal Cancer GT307 injection - Adult | Not applicable | Recruiting | Grit Biotechnology | 18 | 2024-06-28 | 2026-04-14 |
| Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours GT307 injection - Solid Tumor, Adult | Not applicable | Recruiting | Grit Biotechnology | 18 | 2024-04-18 | 2026-01-26 |
China (4)